analiza aiqbench

NVision's POLARIS installation at UCLouvain represents a significant step in applying quantum sensing technologies to biomedical research, specifically for monitoring tumor metabolism and treatment resistance in melanoma. By leveraging quantum-enhanced MRI, this project aims to detect early metabolic shifts that conventional imaging misses, potentially revolutionizing how cancer therapies are evaluated before clinical symptoms appear. This deployment underscores the growing trajectory of quantum sensing from theoretical physics into practical, high-impact applications in oncology research.